XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $927K invested in XTL Biopharmaceuticals in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$72K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $398K | 198,889 | – | – |
|
|
NC
2
Noked Capital
Tel Aviv,
Israel
| $398K | 198,889 | – | – |
|
|
3
Morgan Stanley
New York
| $72K | 36,032 | +1,300 | +4% |
|
4
Invesco
Atlanta,
Georgia
| $52K | 25,961 | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $7K | 3,528 | -2,800 | -44% |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|